Trial initiated for long-lasting injectable PrEP to block HIV transmission
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
Latest findings undertaken by an HIV Impact Assessment (PHIA) Project National which is a multi-country…
Scientists in South Africa have found a link between a particular type of malaria resistance…
While multidrug-resistant forms of infections, such as tuberculosis, have become a growing problem for people…
After decades of shadowboxing with the human immunodeficiency virus, researchers were encouraged four years ago…
Africa is uncharted territory when it comes to sequencing genomes and studying genetic causes for diseases that…
The recent AIDF infographic provides a snapshot of the current health situation in sub-Saharan East…
Zimbabwe will participate in the first ever HIV vaccine research trials conducted in four continents…
On 14 October, Rwandan President Paul Kagame joined a team from a Silicon Valley start-up…
Medical journal, The Lancet publishes the most up-to-date analysis on the state of the world’s…